Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data

@article{Ghouri2010LiverEN,
  title={Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data},
  author={N. Ghouri and D. Preiss and N. Sattar},
  journal={Hepatology},
  year={2010},
  volume={52}
}
  • N. Ghouri, D. Preiss, N. Sattar
  • Published 2010
  • Medicine
  • Hepatology
  • In recent years, a strong link has been established between nonalcoholic fatty liver disease (NAFLD) and the pathogenesis of type 2 diabetes mellitus. The potential role of NAFLD in cardiovascular disease (CVD) has also attracted interest. Published studies have tended to use biochemical and imaging surrogate markers of NAFLD, such as elevated gamma glutamyl transpeptidase (GGT) and alanine aminotransferase (ALT) and fatty liver on ultrasound, when investigating associations with incident CVD… CONTINUE READING
    253 Citations
    Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease
    • 39
    Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population
    • 21

    References

    SHOWING 1-10 OF 42 REFERENCES
    Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.
    • 451
    Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.
    • 520
    • PDF
    Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
    • 1,255
    Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
    • 276